Search

The article presents an itinerary for travelers who plan to go on a trip to the North Pole. It explains that there are flights out of Los Angeles, California to Moscow on board the Russian flag carrier Aeroflot for 900 dollars or from New York via Delta Airlines for 1,000 dollars. Once in Moscow, the journey continues with either another flight to Murmansk or a train ride to Chupa. The article also suggests that the peak ice-diving season is February to April.

The article reports on a meeting organized by local police chief with the administration of U.S. President George W. Bush regarding anticrime funds.

The article deals with the anticipated announcement by former U.S. President Bill Clinton on the price discounts secured by his foundation on medicines for AIDS patients in developing countries on January 12, 2006.

The article presents a reprint of the article "AIDS: The Agony of Africa," by Mark Schoofs, which appeared in the November 9, 1999 issue of "The Village Voice." It features regions in Africa which had been severely affected with AIDS, with Sahara as home to two-thirds of the world's HIV-positive people.

Details the agenda set by South African President Thabo Mbeki to address the economic and social development problems of the country as of October 12, 2004.

Discusses problems with drug procurement for AIDS victims and patients at the Mpilo Chest Hospital in Bulawayo, Zimbabwe, with international assistance from the U.S. Centers for Diseases Control and Prevention and French group Doctors Without Borders.

Focuses on the world-wide AIDS epidemic. How many people in developing countries are not getting efficient treatment and drugs for the disease due to lack of funding and other factors; Description of two major campaigns to fight AIDS; Way that programs are falling short of the goals that were set; Efforts to solve this global problem.

Reports the Clinton Foundation, created by former United States President Bill Clinton, plans to announce deals with several of the world's leading medical companies to cut prices of two HIV diagnostic tests in developing nations. Comments from Jim Kim, adviser to the Director General of the World Health Organization, regarding the importance of diagnostic pricing; Concern among activists related to the test's ease of use in impoverished countries; Discussion of diagnostic pricing; View of doctors regarding the benefits of the tests on the drug treatment regimen given to patients; What the companies are including along with the test kits, including training and the machines necessary to run the tests; Companies that have signed the deal with the Clinton Foundation; Cost to the countries for the CD4 tests.

Presents news briefs on the economy and public finance as of October 17, 2003.

Reports on the protests organized by the Movement for Democratic Change against Zimbabwe President Robert Mugabe.

Reports on the agreement of AIDS researcher David Ho to conduct work on potential therapy and vaccine approaches for severe acute respiratory syndrome.

Reports that independent scientists contested a suggestion by VaxGen Inc. that its experimental AIDS vaccine protected some people against HIV infection.

Deals with the plan of Merck & Co. to reduce the price of its AIDS pill called Stocrin in October 2002.

Highlights the acknowledgement of former U.S. President Bill Clinton that his refusal to lift the ban on federal funding of needle-exchange programs during his presidency was wrong.

Reports on issues about AIDS and approaches empowering women economically through microcredit lending programs and education to prevent the spread of the epidemic as of July 9, 2002.

Discusses the growth of the AIDS epidemic in Russia. Fact that Russia has the world's fastest-growing rate of HIV infections; Prevalence of illicit drug use in Russia; How strict laws have filled the prisons with drug addicts, who spread HIV through shared needles and sexual contact; Concern that the infected prison and drug-using populations could lead to an epidemic within the general population; Description of prison conditions.

Reports on the re-evaluation of anthrax information by the U.S. Federal Bureau of Investigation.

Reports on the results of a study linking genetic patterns to the susceptibility to the side effects of the AIDS drug Ziagen.

Reports on experimental treatments for HIV and AIDS. How certain drugs work; Details on the drugs which were revealed at the Ninth Conference on Retroviruses and Opportunistic Infections; Drugs from companies such as Merck & Co., Tibotec-Virco, Pfizer, and others.

Highlights the presentation made by Merck & Co. on how its experimental AIDS vaccine acts in humans.

Reports on the genetic differences among samples of the Ames strain of anthrax discovered by scientists at the Institute for Genomic Research and Northern Arizona University in Flagstaff.

Reports on the hearings to be conducted by the United States Senate in February 2002 to discuss how the Global Fund to Fight AIDS, Tuberculosis and Malaria plans to enforce it standards.

Reports that the humanitarian group, Doctors Without Borders had defied South African patent law by importing inexpensive generic AIDS drugs manufactured in Brazil for use in a township clinic outside of Capetown.

Reports on the e-mail sent by the United States Federal Bureau of Investigation to microbiologists to ask tips for its anthrax terrorism investigation.

Discusses research on a vaccine to prevent the AIDS virus from causing infected persons to become ill. Dan Barouch, a researcher at Harvard Medical School, and his work testing vaccines on monkeys; How the AIDS virus eventually evaded the vaccinated monkey's immune system; The dangers of creating a partial-protection vaccine to treat AIDS and HIV.

Reports on investigations into anthrax mailed in letters in the United States. Efforts to solve the mystery of where the anthrax came from that killed an elderly woman in Connecticut who had no apparent connection to a post office or media business; Investigation methods, including interviews, analysis of immigrant records, and laboratory work; Details on clues found by investigators.

Discusses the investigation of the anthrax-contaminated letters sent to pediatrician Antonio Banfi in Chile, to the Senate and media offices in the United States.

Reports on the manhunt launched by the United State Federal Bureau of Investigation in connection with the anthrax incidents in several states.

Reports the reaction of the families of the victims of the September 11, 2001 terrorist attack on the World Trade Center in New York City to the United States-led retaliation against Afghanistan.

Reports on examination of steel remains of the collapsed World Trade Center in New York City by Abolhassan Astaneh-Asl, who also examined the collapsed section of the San Francisco-Oakland Bay Bridge.

Reports on use of the Fresh Kills Landfill in Staten Island, New York for dumping wreckage of the World Trade Center following terrorist attacks on the United States. How the landfill was closed due to fears of toxicity; Hopes to find the 'black boxes' of the commercial jets that struck the towers by sifting through the rubble at Fresh Kills; How people have come to Fresh Kills to search for belongings.

Reports on efforts of forensic dentists to identify the bodies of victims pulled from the rubble of the World Trade Center in New York City following terrorist attacks which destroyed buildings. How forensic dentists identify bodies from dental records; Comments from forensic dentist Jeffrey Burkes; Difficulties including extensive incineration or fragmentation of bodies.

Reports on the growth in the number of AIDS patients at the Chris Hani Baragwanath Hospital in Soweto, South Africa as of August 16, 2001.

Discusses the investigation by Tanzania Department of Health on whether a human trial of an experimental AIDS drug, Virodene PO58, was conducted without gaining proper regulatory approval.

Reports on the plan of Nigeria to use cheap generic AIDS drugs starting September 2001.

Reports on the efforts of AngloGold Ltd. to fight against HIV and AIDS in South Africa. Percentages of South African adults infected with HIV; Social and economic conditions that promote the spread of AIDS in South Africa; AngloGold's plans to conduct a clinical study to determine the percentage of its employees who are invected with HIV; Plans of other companies with South African employees including DaimlerChrysler AG and Coco-Cola Co. to supply workers with AIDS treatments.

Profiles Anne Bayley, who first identified the presence of AIDS in Zambia. Career highlights, including how she came to Zambia as a British missionary doctor in 1961; History of the disease's spread in Africa; Patients treated by Bayley at her tumor clinic for Kaposi's sarcoma (KS), whom she recognized as having AIDS; How the association of AIDS with homosexuality greatly inhibited scientific understanding of the disease's transmission; Bayley's contributions to AIDS research; Her personal views on AIDS.

Covers the actions taken by the Treatment Action Campaign, a South African organization, against the high cost of AIDS therapies.

Reports that United Nations Secretary-General Kofi Annan will launch a campaign to reduce prices of AIDS drugs in developing countries.

Reports that more drug-resistant strains of HIV, the AIDS disease virus, are being spread from person to person, according to researchers at a major AIDS conference in Chicago, Illinois in January 2001.

Focuses on studies on treatment interruption among AIDS patients.

Reports on the changes in the AIDS prevention strategy of the United States Centers for Disease Control.

Reports the plans of a research group in the United States to delay the treatment of AIDS patients.

Discusses the problems facing doctors and hospitals in Congo due to civil war there as of December 1, 2000. Use of makeshift supplies and herbal remedies by Jean-Martin Malaba, a doctor in Congo; How international aid is not available due to the conflict.

Focuses on an agreement between several drug companies and the Senegal government on HIV drug price reductions which was reached at an October 2000 meeting in Cairo, Egypt. Background on the price-cut agreement between the Joint United Nations Programme on AIDS and drug companies; Details on the discount plans of drug companies; Significance of the agreement.

Reports on an AIDS treatment study that allows the human immune system to fight off the virus. Study by Bruce Walker at Massachusetts General Hospital in Boston, where recently infected HIV patients were treated with drugs and then stopped using them; Opinion that this study shows an HIV vaccine might be possible; Appearance of the study in the September 2000 edition of 'Nature.'

Focuses on news updates on science in the United States as of August 2000. Views on the similarity between biology and pharmacology; Details on the reporting of the status of AIDS in sub-Saharan Africa.

Focuses on the efforts of Ron Dellum, former congressman in the United States, to campaign for the AIDS Marshall Plan for Africa, a congressional bill that would financially support the fight against the disease. Dellum's record of supporting AIDS issues; Criticism on the budget for the effort; Concerns over the relatedness of AIDS to the social and economic conditions of Africa; Importance of the AIDS Marshall Plan.

Reports on the efforts of the United Nations Security Council in helping Africa cope up with AIDS. Damages the disease is bringing to the country as of January 2000; Why the council should focus on AIDS.